Calidi Biotherapeutics Announces Strategic Partnership with TransferAI to Drive Efficiencies in the IND Submission Process for CLD-401 Using Agentic AI
Summary
SAN DIEGO, April 29, 2026 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE American: CLDI) ('Calidi” or the 'Company”), a biotechnology company pionee...
Description
SAN DIEGO, April 29, 2026 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE American: CLDI) ('Calidi” or the 'Company”), a biotechnology company pionee...
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source